Your browser doesn't support javascript.
loading
First-line therapy for non-transplant eligible patients with multiple myeloma: direct and adjusted indirect comparison of treatment regimens on the existing market in Germany.
Kuhr, Kathrin; Wirth, Daniel; Srivastava, Kunal; Lehmacher, Walter; Hellmich, Martin.
  • Kuhr K; Institute of Medical Statistics, Informatics and Epidemiology, University of Cologne, 50924, Koeln, Germany. kathrin.kuhr@uni-koeln.de.
  • Wirth D; Janssen-Cilag GmbH, Neuss, Germany.
  • Srivastava K; HERON Health Pvt. Ltd, Chandigarh, India.
  • Lehmacher W; BresMed Health Solutions India Pvt. Ltd, Malbhat, Margao, India.
  • Hellmich M; Institute of Medical Statistics, Informatics and Epidemiology, University of Cologne, 50924, Koeln, Germany.
Eur J Clin Pharmacol ; 72(3): 257-65, 2016 Mar.
Article en En | MEDLINE | ID: mdl-26671239
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Mieloma Múltiple / Antineoplásicos Tipo de estudio: Clinical_trials / Guideline / Systematic_reviews Límite: Humans País como asunto: Europa Idioma: En Año: 2016 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Mieloma Múltiple / Antineoplásicos Tipo de estudio: Clinical_trials / Guideline / Systematic_reviews Límite: Humans País como asunto: Europa Idioma: En Año: 2016 Tipo del documento: Article